PARTNER WITH TAIHO PHARMA CANADA TO IMPROVE THE LIVES OF CANCER PATIENTS
TAIHO PHARMA CANADA OFFERS DEEP EXPERIENCE AND STRONG CAPABILITIES THAT MAXIMIZE THE POTENTIAL OF OUR PARTNERS’ ASSETS
- Taiho Pharma Canada is a rapidly growing company whose intense focus on improving life for cancer patients drives all of our efforts
- Deep cancer expertise and functional experience offered by our team – drawn from leading oncology companies across the biopharmaceutical industry
- Strong development, lifecycle management and biomarker capabilities - which means maximizing the clinical potential of your asset
- Highly collaborative culture and approach to partnering
- Nimble, rapid decision-making and execution of a mid-sized, focused company
- Backed by the substantial resources and capabilities of our parent companies
- Proven commercialization track record of success in the Canadian oncology market
- Expansion into Europe for future opportunities
OUR BUSINESS DEVELOPMENT STRATEGY AND PRIORITIES
IN-LICENSING AND ACQUIRING LATE STAGE AND MARKETED ONCOLOGY PRODUCTS MEETING SIGNIFICANT UNMET PATIENT NEEDS
>Indication Focus
- Solid tumors – across tumor types
- Hematological malignancies
>Therapeutic Approach
- Focus on small molecules, but agnostic across therapeutic modalities
- Open to mechanistic approaches – data driven
- Biomarker precision medicine-driven approaches valued
>Development Stage
- Clinical stage candidates in Phase 1b – Phase 3 development
- Marketed products – including “tail products”
- Assets deprioritized for strategic reasons
>Geographic Field
- U.S.
- Canada
- Europe
- Japan/Asia – with our parent Taiho Pharmaceutical Company
CONTACT US
TAIHO ONCOLOGY, INC.
Head Office: 101 Carnegie Center, Suite 101
Princeton, New Jersey 08540
Tel: 609-750-5300
